EAU 2025 Preview: Key Urology Highlights to Watch

EAU at a glance Get ready for EAU 2025 with LucidQuest’s concise preview. We…


LucidTrends

LucidTrends Analysis: Major Depressive Disorder (EU) - March 21st 2025

🔬 What’s Shaping the Future of MDD Treatment Searches Across Europe? Dive into…


Obesity Weekly News

Obesity Weekly News - March 18th 2025

Obesity Updates: Cutting-edge therapies that are reshaping the future of…


Hematology

Hematology Weekly News - March 17th 2025

🚀 Hematology News: Advancements in  blood cancers, acute and chronic leukemias,…


Onco_background

Oncology Weekly Update - March 17th 2025

🚀 Breaking Oncology News: NSCLC, Ovarian Cancer, PROTAC & New Approvals…


Obesity Weekly News

Obesity Weekly News - March 11th 2025

Obesity Drug Updates: Wegovy Price Drop, Mounjaro Expansion & New…


Hematology

Hematology Weekly News - March 11th 2025

 🔬 Hematology Breakthroughs: Clinical trial results, new FDA approvals, and…


Onco_background

Oncology Weekly Update - March 10th 2025

🏥Oncology Update: Imfinzi, TEVIMBRA, Taletrectinib & New Trials Welcome to…


AAD 2025 Preview: Key Dermatology Highlights to Watch

AAD 2025 at a glance With AAD 2025 on the horizon, here’s a preview of…


Obesity Weekly News

Obesity Weekly News - March 4th 2025

🔍 Breakthroughs in Obesity Treatment You Need to Know!…


Hematology

Hematology Weekly News - March 3rd 2025

🔬 Groundbreaking Advances in Hematology:  AML, CML, CLL, multiple myeloma,…


Onco_background

Oncology Weekly Update - March 3rd 2025

Oncology Update: GSK, Enhertu, KEYTRUDA, Cancer Vaccines & More This…


Privacy Preference Center